A detailed history of John G Ullman & Associates Inc transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, John G Ullman & Associates Inc holds 31,742 shares of ZBH stock, worth $3.44 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
31,742
Previous 32,080 1.05%
Holding current value
$3.44 Million
Previous $4.23 Million 18.64%
% of portfolio
0.55%
Previous 0.67%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$106.25 - $130.01 $35,912 - $43,943
-338 Reduced 1.05%
31,742 $3.44 Million
Q1 2024

May 06, 2024

SELL
$119.98 - $132.61 $70,068 - $77,444
-584 Reduced 1.79%
32,080 $4.23 Million
Q4 2023

Jan 31, 2024

BUY
$102.72 - $121.7 $3.36 Million - $3.98 Million
32,664 New
32,664 $3.98 Million
Q4 2019

Jan 29, 2020

SELL
$127.4 - $146.83 $191,100 - $220,245
-1,500 Closed
0 $0
Q3 2019

Oct 21, 2019

SELL
$113.33 - $138.46 $1.03 Million - $1.26 Million
-9,090 Reduced 85.84%
1,500 $206,000
Q2 2019

Aug 02, 2019

SELL
$108.87 - $125.09 $10,887 - $12,509
-100 Reduced 0.94%
10,590 $1.25 Million
Q1 2019

Apr 30, 2019

SELL
$97.5 - $125.79 $6,532 - $8,427
-67 Reduced 0.62%
10,690 $1.37 Million
Q4 2018

Jan 29, 2019

SELL
$94.4 - $126.76 $41,064 - $55,140
-435 Reduced 3.89%
10,757 $1.12 Million
Q3 2018

Nov 02, 2018

BUY
$108.41 - $127.64 $25,476 - $29,995
235 Added 2.14%
11,192 $1.47 Million
Q2 2018

Jul 23, 2018

SELL
$102.12 - $114.04 $17,054 - $19,044
-167 Reduced 1.5%
10,957 $1.22 Million
Q1 2018

Apr 19, 2018

BUY
$104.31 - $124.46 $5,215 - $6,223
50 Added 0.45%
11,124 $1.21 Million
Q4 2017

Jan 31, 2018

SELL
$105.55 - $120.83 $21,110 - $24,166
-200 Reduced 1.77%
11,074 $1.34 Million
Q3 2017

Nov 03, 2017

BUY
$106.92 - $117.79 $1.21 Million - $1.33 Million
11,274
11,274 $1.32 Million

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $22.7B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track John G Ullman & Associates Inc Portfolio

Follow John G Ullman & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of John G Ullman & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on John G Ullman & Associates Inc with notifications on news.